Due to the observational nature of the NCDB, the HER2 IHC and ISH results were based on reports from cancer centers and were not confirmed in a central pathology laboratory, which is needed, as in most cases there can be disparities in the IHC reports provided by pathologists [40]. This evidence concerns the gene ERBB2 and cancer.